Weigelt B B - OmicsDI

Show results for

Unknown (270)
Transcriptomics (11)
Genomics (1)
Metabolomics (1)

Organisms

Pimephales promelas (4)
Homo sapiens (4)
Mus musculus (3)

Repository

biostudies-arrayexpress (12)
MetaboLights (1)

Disease

Triple negative breast cancer (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2014 (2)
2010 (2)
2009 (2)
2008 (2)
2016 (1)
2013 (1)
2011 (1)
2007 (1)
2025 (1)

Metabolite Name

(+)-(3,3''-bi-4H-1-benzopyran)-4,4''-dione,2,2'',3,3''-tetrahydro-5,5'',7''-trihydroxy-7-methoxy-2-(4-methoxyphenyl)-2''-(4-hydroxyphenyl) (1)
(+)-Medioresinol (1)
(+)-zuonin A (1)
(+-)-9-(2-Cyanoethyl)dihydrozeatin (1)
(+/-)-oxiran-2-ylmethyl (9Z)-hexadec-9-enoate (1)
(-)-Amurensisin (1)
(-)-Epicatechin(4.beta.-->8)(-)-epigallocatechin (1)
(-)-yatein (1)
(1-methyl-5-nitroimidazol-2-yl)methyl N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate (1)
(10S,13R,14R,16R,17R)-16-hydroxy-17-[(2R)-1-hydroxy-6-methylhept-5-en-2-yl]-4,4,10,13,14-pentamethyl-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one (1)
(1E)-1-[2,2,4-trimethyl-3-[(1E,3E,5E,7E,9E)-3,7,12-trimethyltrideca-1,3,5,7,9,11-hexaenyl]cyclohex-3-en-1-ylidene]propan-2-one (1)
(1E,3E,5E,7E,9E,11E,13E,15Z)-1-[(2R,4S)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-16-(hydroxymethyl)-18-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-3,7,12-trimethyloctadeca-3,5,7,9,11,13,15-heptaen-17-yn-2-one (1)
(1E,4E)-1-(3,4-dimethoxyphenyl)-5-(4-hydroxy-3-methoxyphenyl)penta-1,4-dien-3-one (1)
(1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(2-hydroxyphenyl)hepta-1,6-diene-3,5-dione (1)
(1R)-3,5,5-trimethyl-4-[(3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-3,5,7,9,11,13,15,17-octaen-1-ynyl]cyclohex-3-en-1-ol (1)
(1R,2R,3S,4S)-4-(2-hydroxyethyl)-2,3-bis(phenylmethoxymethyl)cyclopentan-1-ol (1)
(1R,2R,4S,4aS,6aS,6aS,6bR,12aS,14bS)-1,4,11-trihydroxy-1,2,6a,6b,9,12a-hexamethyl-10-oxo-2,3,4,5,6,6a,7,8,13,14b-decahydropicene-4a-carboxylic acid (1)
(1R,2R,4aS,6aR,6aS,6bR,8R,8aR,10S,12aR,14bS)-1,8,10-trihydroxy-1,2,6a,6b,12a-pentamethyl-9-methylidene-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid (1)
(1R,2R,4aS,6aR,6aS,6bR,8aR,10S,11R,12aR,14bS)-1,10,11-trihydroxy-1,2,6a,6b,12a-pentamethyl-9-methylidene-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid (1)
(1R,2S,4S,4aS,8aS)-4a,8,8-trimethyl-1,2,3,4,5,6,7,8a-octahydronaphthalene-1,2,4-triol (1)
(1R,3R,4S,5R)-1,3,4-trihydroxy-5-[(E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyl]oxycyclohexane-1-carboxylic acid (1)
(1R,3aS,4E,7aR)-4-[2-[(3R,5R)-3,5-dimethyl-4-methylidenecyclohexylidene]ethylidene]-7a-methyl-1-[(E,2S)-6-methylhept-3-en-2-yl]-2,3,3a,5,6,7-hexahydro-1H-indene (1)
(1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-9-oxo-1-prop-1-en-2-yl-2,3,4,5,6,7,7a,11b,12,13,13a,13b-dodecahydro-1H-cyclopenta[a]chrysene-3a-carbaldehyde (1)
(1R,3aS,5aS,5bR,7aR,11aR,11bR,13aR,13bR)-5b,8,8,11a-tetramethyl-7,9-dioxo-1-prop-1-en-2-yl-1,2,3,4,5,6,7a,10,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysene-3a,5a-dicarboxylic acid (1)
(1R,4R,7R,8R,10R,13R,14S)-13,14-diethyl-7-[(3R,4S,6R)-3-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,6,6,8,10-pentamethyl-17-[4-(4-pyridin-4-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone (1)
(1R,4aR,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1-hydroxy-1,6a,6b,9,9,12a-hexamethyl-2-methylidene-10-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy-4,5,6,6a,7,8,8a,10,11,12,13,14b-dodecahydro-3H-picene-4a-carboxylic acid (1)
(1R,4aS,4bR,6aS,7S,10aS,10bR,12S,12aS)-2-acetyl-12-acetyloxy-7-ethyl-4b,7,10a,12a-tetramethyl-1,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydrochrysene-1-carboxylic acid (1)
(1R,4aS,6bR,10S,12aR,14bS)-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid (1)
(1R,8S,9R,10R,12R)-9,10,12-trihydroxy-3,7,11-trioxabicyclo[6.3.1]dodecane-4,6-dione (1)
(1S,2R,4aS,6aR,6aR,6bR,8aR,12aR,14bS)-1,2,6b,9,9,12a-hexamethyl-10-oxo-1,2,3,4,5,6,6a,7,8,8a,11,12,13,14b-tetradecahydropicene-4a,6a-dicarboxylic acid (1)

Study type

Transcription profiling by array (9)
RNAi profiling by array (1)
Comparative genomic hybridization by array (1)
ChIP-seq (1)

Release Date

2022 (36)
2016 (26)
2024 (25)
2021 (25)
2020 (25)
2019 (23)
2017 (22)
2023 (21)
2018 (16)
2025 (14)
2015 (13)
2014 (10)
2012 (5)
2013 (4)
2010 (4)
2011 (3)
2009 (2)
2008 (2)
2007 (2)
2026 (2)
2005 (1)
2003 (1)

Previous page
1 / 29
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 29
Next page

Sort by:

Relevance

Page size

Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial Carcinoma.

Not available

S-EPMC9664177 | biostudies-literature

Transcription profiling of human invasive breast cancer carcinomas with different histological types and invasive lobular carcinoma

Gene expression array analysis on a series of ten different histological special types of invasive breast carcinomas (tubular, micropapillary, mucinous A, mucinous B, endocrine, apocrine, metaplastic, medullary, adenoid cystic, invasive ductal carcinoma with osteoclastic giant cells) and invasive lo...

ORGANISM(S): Homo sapiens

2010-08-20 | E-NCMF-3 | biostudies-arrayexpress

Synthesis and hydrogenation of polycyclic aromatic hydrocarbon-substituted diborenes via uncatalysed hydrogenative B-C bond cleavage.

Not available

S-EPMC9242019 | biostudies-literature

Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol.

Not available

S-EPMC8578987 | biostudies-literature

Transcription profiling of human invasive breast cancer carcinomas with different histological types and invasive lobular carcinoma

Not available

ORGANISM(S): Homo sapiens

S-ECPF-NCMF-3 | biostudies-other

Identification of PU.1 target genes by expression profiling of PUER cells

PU.1 is a key transcription factor for macrophage differentiation. Novel PU.1 target genes were identified by mRNA profiling of PU.1-deficient progenitor cells (PUER) before and after PU.1 activation. We used two different types of Affymetrix DNA-microarrays (430 2.0 arrays and ST 1.0 exon arrays) t...

ORGANISM(S): Mus musculus

2008-10-11 | E-GEOD-13125 | biostudies-arrayexpress

RNAi knock down of ADP-glucose pyrophosphorylase (AGP) in Pisum sativum developing cotyledons

During seed growth, sugar and nitrogen compounds confer regulatory control on storage activities. Thus, seed storage production could be regulated by the supply of nutrients. In order to improve nitrogen flux into the embryo, transgenic pea lines were created where ADP-glucose pyrophosphorylase (AGP...

ORGANISM(S): Pisum sativum

2008-09-01 | E-MEXP-1749 | biostudies-arrayexpress

Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement.

Not available

S-EPMC3079850 | biostudies-literature

Transcription profiling of human breast carcinomas negative for estrogen, progesterone and HER2/nue receptors

97 triple negative tumors were selected from the fresh-frozen tissue bank of the Netherlands Cancer Institute and gene expression profiles were generated using 35K oligonucleotide microarrays. Human breast carcinomas were snap frozen in liquid nitrogen within one hour after surgery and stored in the...

ORGANISM(S): Homo sapiens

2007-10-09 | E-NCMF-2 | biostudies-arrayexpress

Transcription profiling of human breast cancer cell line comparing RNA of spheres with co-responding parental cell line

n=18, 36 arrays, RNA of spheres versus RNA of corresponding parental cell line

ORGANISM(S): Homo sapiens

2009-04-24 | E-NCMF-25 | biostudies-arrayexpress

Previous page
1 / 29
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 29
Next page

Sort by:

Relevance

Page size

283 Results

Show results for

Organisms

Repository

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

Study type

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets